Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STANDARD BIOTOOLS INC.FLDM · Entity 6116 | Director | May 25, 2021 | May 27, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STANDARD BIOTOOLS INC.
Report date May 25, 2021 · Filed May 27, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,563 |
Reported balance
After 2021-05-25 transaction · row 1
1 source rowRow 1 · 2021-05-25 · Grant · Acquired 10,342 · Balance 18,563 F1: The Restricted Stock Units vest in full on the earlier to occur of May 25, 2022 and one day prior to the date of the Company's next annual meeting of stockholders. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.56 · Expires 2031-05-25 | Direct | 15,402 |
Reported balance
After 2021-05-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-05-25 · Grant · Acquired 15,402 · Balance 15,402 F2: The Option becomes exercisable in twelve equal monthly increments beginning on June 25, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units vest in full on the earlier to occur of May 25, 2022 and one day prior to the date of the Company's next annual meeting of stockholders.
F2: The Option becomes exercisable in twelve equal monthly increments beginning on June 25, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 25, 2021 Filed May 27, 2021 21:30 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 15,402 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001162194-21-000060 · wf-form4_162215090555245.xml · derivative · entry 2 Stankovic Ana K. · CIK 0001835735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,402 Underlying: Common Stock · 15,402 shares Expires 2031-05-25 F2 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly increments beginning on June 25, 2021. Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:30 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantCommon Stock | 10,342 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000060 · wf-form4_162215090555245.xml · nonDerivative · entry 1 Stankovic Ana K. · CIK 0001835735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,563 F1 · shares: The Restricted Stock Units vest in full on the earlier to occur of May 25, 2022 and one day prior to the date of the Company's next annual meeting of stockholders. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 22:24 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 12,237 | $0.00 Strike: $6.69 | $0.00 |
DisclosureSEC source: 0001162194-20-000122 · wf-form4_160824383499886.xml · derivative · entry 2 Stankovic Ana K. · CIK 0001835735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,237 Underlying: Common Stock · 12,237 shares Expires 2030-12-15 F2 · derivative.exercise_date: The Option becomes exercisable in four equal annual increments beginning on December 15, 2021. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 22:24 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantCommon Stock | 8,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000122 · wf-form4_160824383499886.xml · nonDerivative · entry 1 Stankovic Ana K. · CIK 0001835735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,221 F1 · shares: Represents Restricted Stock Units that vest in four equal annual increments beginning December 15, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.